These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 18757184)

  • 1. Vaccination and passive immunisation against Staphylococcus aureus.
    Schaffer AC; Lee JC
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal vaccines and immunotherapies.
    Schaffer AC; Lee JC
    Infect Dis Clin North Am; 2009 Mar; 23(1):153-71. PubMed ID: 19135920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
    Fattom AI; Horwith G; Fuller S; Propst M; Naso R
    Vaccine; 2004 Feb; 22(7):880-7. PubMed ID: 15040941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.
    Creech CB; Johnson BG; Alsentzer AR; Hohenboken M; Edwards KM; Talbot TR
    Vaccine; 2009 Dec; 28(1):256-60. PubMed ID: 19799842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic strategies to combat staphylococcal infections.
    Ohlsen K; Lorenz U
    Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.
    Vernachio JH; Bayer AS; Ames B; Bryant D; Prater BD; Syribeys PJ; Gorovits EL; Patti JM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):511-8. PubMed ID: 16436704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.
    Fattom A; Fuller S; Propst M; Winston S; Muenz L; He D; Naso R; Horwith G
    Vaccine; 2004 Dec; 23(5):656-63. PubMed ID: 15542186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R; Lacasse P; Grondin G; Talbot BG
    Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic approaches against Staphylococcus aureus.
    Verkaik NJ; van Wamel WJ; van Belkum A
    Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J; Anderson R; Anderson AS
    Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.
    Nour El-Din AN; Shkreta L; Talbot BG; Diarra MS; Lacasse P
    Vaccine; 2006 Mar; 24(12):1997-2006. PubMed ID: 16426711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
    Pellegrino M; Giraudo J; Raspanti C; Nagel R; Odierno L; Primo V; Bogni C
    Vet Microbiol; 2008 Feb; 127(1-2):186-90. PubMed ID: 17869031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus.
    Kerro-Dego O; Prysliak T; Potter AA; Perez-Casal J
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):125-38. PubMed ID: 16777237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response.
    Holtfreter S; Kolata J; Bröker BM
    Int J Med Microbiol; 2010 Feb; 300(2-3):176-92. PubMed ID: 19889576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus vaccine conjugate--Nabi: Nabi-StaphVAX, StaphVAX.
    Drugs R D; 2003; 4(6):383-5. PubMed ID: 14584973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.
    Robbins JB; Schneerson R; Horwith G; Naso R; Fattom A
    Am Heart J; 2004 Apr; 147(4):593-8. PubMed ID: 15077073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.